Response to Comments: Immune Thrombocytopenia (ITP) Therapy

This document is an administrative notice recording responses to comments on proposed LCD DL38268 (Immune Thrombocytopenia Therapy) and provides the comment, notice, and finalization dates. It does not contain clinical coverage criteria, limitations, documentation requirements, or frequency limits; consult the final LCD DL38268 for the substantive policy content and coverage rules.